Marek K - Search Results

1

Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study.

Fullard ME, Xie SX, Marek K, Stern M, Jennings D, Siderowf A, Willis AW, Chen-Plotkin AS. Fullard ME, et al. Among authors: marek k. Mov Disord. 2017 Nov;32(11):1636-1640. doi: 10.1002/mds.27127. Epub 2017 Sep 14. Mov Disord. 2017. PMID: 28906025 Free PMC article.

2

Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.

Seibyl JP, Marek K, Sheff K, Zoghbi S, Baldwin RM, Charney DS, van Dyck CH, Innis RB. Seibyl JP, et al. Among authors: marek k. J Nucl Med. 1998 Sep;39(9):1500-8. J Nucl Med. 1998. PMID: 9744331 Free article.

3

Do dopamine agonists or levodopa modify Parkinson's disease progression?

Marek K, Jennings D, Seibyl J. Marek K, et al. Eur J Neurol. 2002 Nov;9 Suppl 3:15-22. doi: 10.1046/j.1468-1331.9.s3.2.x. Eur J Neurol. 2002. PMID: 12464117 Review.

4

Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients.

Stern MB, Marek KL, Friedman J, Hauser RA, LeWitt PA, Tarsy D, Olanow CW. Stern MB, et al. Mov Disord. 2004 Aug;19(8):916-23. doi: 10.1002/mds.20145. Mov Disord. 2004. PMID: 15300656 Clinical Trial.

5

(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis.

Jennings DL, Seibyl JP, Oakes D, Eberly S, Murphy J, Marek K. Jennings DL, et al. Among authors: marek k. Arch Neurol. 2004 Aug;61(8):1224-9. doi: 10.1001/archneur.61.8.1224. Arch Neurol. 2004. PMID: 15313838

6

Neuroimaging trials of Parkinson's disease progression.

Seibyl J, Jennings D, Tabamo R, Marek K. Seibyl J, et al. Among authors: marek k. J Neurol. 2004 Oct;251 Suppl 7:vII9-13. doi: 10.1007/s00415-004-1704-5. J Neurol. 2004. PMID: 15505753 Review. No abstract available.

7

Unique roles of SPET brain imaging in clinical and research studies. Lessons from Parkinson's disease research.

Seibyl J, Jennings D, Tabamo R, Marek K. Seibyl J, et al. Among authors: marek k. Q J Nucl Med Mol Imaging. 2005 Jun;49(2):215-21. Q J Nucl Med Mol Imaging. 2005. PMID: 16010256 Free article. Review.

8

The role of neuroimaging in the early diagnosis and evaluation of Parkinson's disease.

Seibyl J, Jennings D, Tabamo R, Marek K. Seibyl J, et al. Among authors: marek k. Minerva Med. 2005 Oct;96(5):353-64. Minerva Med. 2005. PMID: 16227950 Review.

9

Fatigue in levodopa-naive subjects with Parkinson disease.

Schifitto G, Friedman JH, Oakes D, Shulman L, Comella CL, Marek K, Fahn S; Parkinson Study Group ELLDOPA Investigators. Schifitto G, et al. Among authors: marek k. Neurology. 2008 Aug 12;71(7):481-5. doi: 10.1212/01.wnl.0000324862.29733.69. Neurology. 2008. PMID: 18695158 Free PMC article. Clinical Trial.

10

Clinical correlates of depressive symptoms in familial Parkinson's disease.

Pankratz N, Marder KS, Halter CA, Rudolph A, Shults CW, Nichols WC, Foroud T; Parkinson's Study Group-PROGENI Investigators. Pankratz N, et al. Mov Disord. 2008 Nov 15;23(15):2216-23. doi: 10.1002/mds.22285. Mov Disord. 2008. PMID: 18785635 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

441 results

Search Page